February 21st 2025
The Trump administration argues that HHS Secretary Robert F. Kennedy Jr can overrule the US Preventive Services Task Force to determine the preventive services covered under the Affordable Care Act.
Segment 4: Reimbursement and Clinical Pathways
July 18th 2013This segment of the panel discussion takes a closer look at the episode of cost for a patient going to a hospital versus a private office setting. Panelists agree that the cost of hospital care is not that much greater than in the office.
Read More
Segment 3: How Payers are assessing the Value of New Agents
July 18th 2013Dr. Chernew asks the panelists how payers address the value of these costly combination therapies when there are less expensive options available. Dr. Newcomer says that the drugs being discussed are, in fact, having a significant clinical effect.
Read More
Previously Unrecognized Trends in Diabetes Consumption Clusters in Medicare
Medicare beneficiaries with diabetes who are at the lowest levels of healthcare consumption often become some of the highest level consumers in subsequent years.
Read More
Accountable Care Organizations Begin to Show Promise
July 11th 2013Insurer UnitedHealth Group recently noted it will more than double payments made to physicians who participate in accountable care contacts. ACOs have already demonstrated an immense positive growth in quality care, and a reduction in medical costs.
Read More
Federal 340b Drug Discount Program May be Reformed
July 10th 2013New recommendations suggest reforming the federal 340b drug discount program. Originally designed to help providers serve the poor or underinsured, misuse has raised concerns for greater transparency in prices and how hospitals are using 340b savings.
Read More
A Push for Collaborative Care Calls ACO Models into Question
July 5th 2013In January 2012, 32 healthcare organizations became the first to participate in the Medicare Pioneer Accountable Care Organization (ACO) model. Now, over a year into the initiative, as many as 9 organizations are in deliberation of leaving the program.
Read More
Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes
Read More